The Europe probiotics market is estimated to grow to nearly USD 15.62 Billion by 2023 with a CAGR of 5.68% from USD 11.85 billion in 2018. Europe is a fast growing market segment. Europe started providing probiotic at the general grocery stores and super markets to increase the awareness in public. Germany is the largest market in Europe holding a large share value. While Switzerland and Russia are expected to grow at a high CAGR in the forecast period.
Probiotics are widely found in the dietary and mainly dairy products containing strained bacteria like streptococcus, yeast and lactobacillus. Having a strong gut health helps in developing strong immune system for the body. Probiotics are usually prescribed by the doctors after prolonged illness with antibiotic consumption. They destroy the microorganisms left in the intestine.
In the European region increase in health conscious drives the overall demand for probiotics. Widespread intestinal diseases can be cured by the use of probiotics and such type of functional foods. The restrain for the market is the stability of the probiotic organisms, as they easily damaged so need careful manufacturing, storing and transporting.
Depending upon end use the market is divided into animal and human probiotics market. By application it can be bifurcated into animal feed, food & beverages (Dairy Products, Non-Dairy Products, Cereals, Baked Foods, Fermented Meat Products and Dry Food Probiotics) and dietary supplements (Food Supplements, Nutritional Supplements, Speciality Nutrients and Infant Formula). Based upon the type of bacteria they can be segmented into streptococcus, lactobacillus, yeast and others. Dietary supplement segment is estimated to achieve highest growth due to increasing awareness.
The key players in the market are General mills, China-Biotics, Yakult Honsha Co. Ltd., Mother dairy, Nestle S.A, PROBI AB, E.I. du Pont de Nemours and company, Chr. Hansen, Lifeway foods, Groupe Danone S.A. and many others.
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 By Bacteria Type
5.1.1 Streptococcus
5.1.2 Lactobacillus
5.1.3 Yeast
5.1.4 Other Bacterias
5.2 By Application
5.2.1 Animal Feed
5.2.2 Food and Beverages
5.2.2.1 Dairy Products
5.2.2.2 Non-Dairy Products
5.2.2.3 Cereals
5.2.2.4 Baked Foods
5.2.2.5 Fermented Meat Products
5.2.2.6 Dry Food Probiotics
5.2.3 Dietary Supplements
5.2.3.1 Food Supplements
5.2.3.2 Nutritional Supplements
5.2.3.3 Speciality Nutrients
5.2.3.4 Infant Formula
5.3 By End Use
5.3.1 Animal Probiotics
5.3.2 Human Probiotics
6. Geographical Analysis
6.1 Introduction
6.2 U.K
6.3 Spain
6.4 Germany
6.5 Italy
6.6 France
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 General mills
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 China-Biotics
8.3 Yakult Honsha Co. Ltd
8.4 Mother dairy
8.5 Nestle S.A
8.6 PROBI AB
8.7 E.I. du Pont de Nemours and company
8.8 Chr. Hansen
8.9 Lifeway foods
8.10 Groupe Danone S.A.
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Expert Opinions
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
